-
Je něco špatně v tomto záznamu ?
The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease
L. Kunovsky, Z. Kala, F. Marek, J. Dolina, K. Poredska, L. Kucerova, K. Benesova, L. Mitas,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Odkazy
PubMed
30069743
DOI
10.1007/s00384-018-3122-7
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- Crohnova nemoc genetika chirurgie MeSH
- dospělí MeSH
- genetická predispozice k nemoci MeSH
- genetické asociační studie MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace genetika MeSH
- prognóza MeSH
- rizikové faktory MeSH
- signální adaptorový protein Nod2 genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: Crohn's disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing (NOD2/CARD15) can be used in patients with CD to predict the need for surgical treatment (to define an aggressive type of disease where the patient can profit from early surgery). METHODS: The patients who were tested genetically had undergone a surgery due to CD at the Department of Surgery University Hospital Brno Bohunice between 2010 and 2016. The control group consisted of patients with CD who had been diagnosed with CD at least 5 years prior to the testing and had not required any surgical intervention. The second control group was healthy subjects. RESULTS: In total, there were 117 operated patients for CD, 77 patients with CD that had not undergone surgery for CD and 30 healthy subjects. For patients with at least one genetic mutation, the risk of the necessity of surgical treatment of CD is 1.96 times higher than for patients with no mutation. Patients with two or more mutations were generally operated on at a younger age, in a shorter time after being diagnosed and each patient had a partial resection of the ileum. CONCLUSION: The group of operated patients with CD had a significantly higher distribution of at least one genetic mutation as opposed to the non-operated group. In patients with two or more mutations, the disease course was more aggressive. This group of patients might profit from the conservative top-down or early surgical therapy.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028290
- 003
- CZ-PrNML
- 005
- 20190823085012.0
- 007
- ta
- 008
- 190813s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00384-018-3122-7 $2 doi
- 035 __
- $a (PubMed)30069743
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Kunovsky, L $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 245 14
- $a The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease / $c L. Kunovsky, Z. Kala, F. Marek, J. Dolina, K. Poredska, L. Kucerova, K. Benesova, L. Mitas,
- 520 9_
- $a PURPOSE: Crohn's disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing (NOD2/CARD15) can be used in patients with CD to predict the need for surgical treatment (to define an aggressive type of disease where the patient can profit from early surgery). METHODS: The patients who were tested genetically had undergone a surgery due to CD at the Department of Surgery University Hospital Brno Bohunice between 2010 and 2016. The control group consisted of patients with CD who had been diagnosed with CD at least 5 years prior to the testing and had not required any surgical intervention. The second control group was healthy subjects. RESULTS: In total, there were 117 operated patients for CD, 77 patients with CD that had not undergone surgery for CD and 30 healthy subjects. For patients with at least one genetic mutation, the risk of the necessity of surgical treatment of CD is 1.96 times higher than for patients with no mutation. Patients with two or more mutations were generally operated on at a younger age, in a shorter time after being diagnosed and each patient had a partial resection of the ileum. CONCLUSION: The group of operated patients with CD had a significantly higher distribution of at least one genetic mutation as opposed to the non-operated group. In patients with two or more mutations, the disease course was more aggressive. This group of patients might profit from the conservative top-down or early surgical therapy.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a Crohnova nemoc $x genetika $x chirurgie $7 D003424
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a signální adaptorový protein Nod2 $x genetika $7 D053473
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kala, Z $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
- 700 1_
- $a Marek, F $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. fillip.marek@email.cz.
- 700 1_
- $a Dolina, J $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Poredska, K $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kucerova, L $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Benesova, K $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Mitas, L $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
- 773 0_
- $w MED00002307 $t International journal of colorectal disease $x 1432-1262 $g Roč. 34, č. 2 (2019), s. 347-351
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30069743 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823085227 $b ABA008
- 999 __
- $a ok $b bmc $g 1433439 $s 1066750
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 34 $c 2 $d 347-351 $e 20180802 $i 1432-1262 $m International journal of colorectal disease $n Int J Colorectal Dis $x MED00002307
- LZP __
- $a Pubmed-20190813